Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Takeda
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Novartis
Thomas Jefferson University
Novartis
Novartis
OHSU Knight Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Stanford University
Washington University School of Medicine
University of Nebraska
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
Stanford University
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Fred Hutchinson Cancer Center
University of Michigan Rogel Cancer Center
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Alabama at Birmingham
Pfizer
Wake Forest University Health Sciences
Teva Branded Pharmaceutical Products R&D, Inc.
Duke University
Institut Bergonié
Novartis
Novartis
Novartis
Novartis
National Institutes of Health Clinical Center (CC)
Nohla Therapeutics, Inc.
Novartis
National Institutes of Health Clinical Center (CC)
Novartis
M.D. Anderson Cancer Center
Takeda
M.D. Anderson Cancer Center